Apple in healthcare. All things CPG. MoneyTree Report.
Death & anxiety
Our Q4’18 MoneyTree report, which tracks global VC activity and is done in partnership with PwC, came out today.
There’s been a lot of great and interesting media coverage of the report, which we’ll highlight over the coming days.
One interesting analysis was done by The Financial Times, which compared the trend in Asian tech investment with that of the US.
The next Silicon Valley — if there is one — is coming out of Asia, it seems (likely China).
Sidenote: I will be in Beijing next Saturday speaking at EmTech China hosted by MIT Tech Review. If you’re in Beijing doing interesting things in corporate transformation, investment, or tech, I would love to catch up if possible. Drop me a line.
Back to the 2019 VC stats — check out the full FT article in the Industry Standard below.
On February 12, we’ll be at Samsung in San Jose to host our next executive forum, Councils, and discuss how to measure return on innovation.
If you are an SVP or higher leading strategy, innovation, digital transformation, CVC, or any group driving transformational investment at a large enterprise ($1B+ revenue), it’s a topic that is likely near and dear to your heart.
We’ll be hearing from several companies about how they do it and also be presenting CB Insights research on the topic.
With over $7T in health spending per year, healthcare accounts for nearly 10% of global GDP. The market opportunity is huge, and Apple is taking advantage of it.
We explore Apple’s developments in the space — like the Apple Health Record and Apple Watch with a single-lead ECG — and what lies ahead. Read all about it here.
Why so anxious?
On Twitter, we asked how you feel when you see a competitor failing. Here are the results:
TBH, I’m very surprised by this. Perhaps a lot of non-entrepreneurs responded to the poll, but the level of anxiety that folks feel when a competitor is dying seems odd.
Does that mean that folks don’t think their businesses or markets are solid? We’ve had numerous CBI competitors die during our lifetime (all more well-funded, btw), and each time we take joy in it for 5 minutes and then get back to work.
Sometimes we go looking for talent or customers, but most of the time, the demise was predictable and so the good people have all already left.
But the death of a competitor has never made us worry about our business.
That doesn’t mean we don’t worry (constantly) about our business for other reasons, like:
Are we building the right products?
Are we taking care of clients?
Are we hiring and retaining the best people?
Are we starting to act like our isht don’t stink?
Are we moving fast enough?
Are we disciplined and deliberate in our decision-making?
Are we actively killing complexity?
Yes, we worry a lot. But not about the competition.